{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:29:40Z","timestamp":1766467780513,"version":"3.44.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["23-A1-00-1008299"],"award-info":[{"award-number":["23-A1-00-1008299"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Health"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10900-025-01460-y","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T02:49:17Z","timestamp":1742179757000},"page":"725-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Naloxone Acceptance among Nightclub Attendees in New York City"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7079-2003","authenticated-orcid":false,"given":"Nina","family":"Abukahok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-9655","authenticated-orcid":false,"given":"Amanda M.","family":"Bunting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Palamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"1460_CR1","unstructured":"Centers for Disease Control and Prevention (2024). US overdose deaths decrease in 2023, first time since 2018. National Center for Health Statistics. Retrieved December 4th, 2024 from https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm#:~:text=Provisional%20data%20from%20CDC%E2%80%99s%20National,drug%20overdose%20deaths%20since%202018"},{"issue":"10","key":"1460_CR2","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/ajph.2018.304590","volume":"108","author":"AL Pitt","year":"2018","unstructured":"Pitt, A. L., Humphreys, K., & Brandeau, M. L. (2018). Modeling health benefits and harms of public policy responses to the US opioid epidemic. American Journal of Public Health, 108(10), 1394\u20131400. https:\/\/doi.org\/10.2105\/ajph.2018.304590","journal-title":"American Journal of Public Health"},{"issue":"2","key":"1460_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/14740338.6.2.125","volume":"6","author":"E van Dorp","year":"2007","unstructured":"van Dorp, E., Yassen, A., & Dahan, A. (2007). Naloxone treatment in opioid addiction: The risks and benefits. Expert Opinion on Drug Safety,6(2), 125\u2013132. https:\/\/doi.org\/10.1517\/14740338.6.2.125","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"1460_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12954-023-00904-9","volume":"20","author":"KR Marks","year":"2023","unstructured":"Marks, K. R., Oyler, D. R., Strickland, J. C., Jaggers, J., Roberts, M. F., Miracle, D. K., Barnes, C., Lei, F., Smith, A., Mackin, E., Martin, M. C., & Freeman, P. R. (2023). Bystander preference for Naloxone products: A field experiment. Harm Reduction Journal,20(1), 171. https:\/\/doi.org\/10.1186\/s12954-023-00904-9","journal-title":"Harm Reduction Journal"},{"issue":"13","key":"1460_CR5","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1177\/0009922819877870","volume":"58","author":"B Slingsby","year":"2019","unstructured":"Slingsby, B., Moore, J. L., & Barron, C. E. (2019). Infant and toddler ingestion of illicit Fentanyl: A case series. Clinical Pediatrics (Phila),58(13), 1449\u20131451. https:\/\/doi.org\/10.1177\/0009922819877870","journal-title":"Clinical Pediatrics (Phila)"},{"key":"1460_CR6","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal Naloxone distribution in Massachusetts: Interrupted time series analysis. Bmj, 346, f174. https:\/\/doi.org\/10.1136\/bmj.f174","journal-title":"Bmj"},{"issue":"23","key":"1460_CR7","first-page":"631","volume":"64","author":"E Wheeler","year":"2015","unstructured":"Wheeler, E., Jones, T. S., Gilbert, M. K., & Davidson, P. J. (2015). Opioid overdose prevention programs providing Naloxone to Laypersons - United States, 2014. Mmwr. Morbidity and Mortality Weekly Report, 64(23), 631\u2013635. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4584734\/pdf\/631-635.pdf","journal-title":"Mmwr. Morbidity and Mortality Weekly Report"},{"issue":"8","key":"1460_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.7326\/m23-0852","volume":"176","author":"CM John","year":"2023","unstructured":"John, C. M., Leo, B., Aaron, S. K., Rachel, E. B., Kesselheim, S., Rachel, E., & Barenie, J. D. (2023). Moving Naloxone Over the Counter Is Necessary but Not Sufficient. Annals of Internal Medicine,176(8), 1109\u20131112. https:\/\/doi.org\/10.7326\/m23-0852","journal-title":"Annals of Internal Medicine"},{"key":"1460_CR9","doi-asserted-by":"publisher","first-page":"108785","DOI":"10.1016\/j.jsat.2022.108785","volume":"139","author":"SG Weiner","year":"2022","unstructured":"Weiner, S. G., Carroll, A. D., Brisbon, N. M., Rodriguez, C. P., Covahey, C., Stringfellow, E. J., DiGennaro, C., Jalali, M. S., & Wakeman, S. E. (2022). Evaluating disparities in prescribing of Naloxone after emergency department treatment of opioid overdose. Journal of Substance Abuse Treatment, 139, 108785. https:\/\/doi.org\/10.1016\/j.jsat.2022.108785","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"1460_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1353\/hpu.2010.0935","volume":"21","author":"AR Bazazi","year":"2010","unstructured":"Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010). Preventing opiate overdose deaths: Examining objections to take-home Naloxone. Journal of Health Care for the Poor and Underserved, 21(4), 1108\u20131113. https:\/\/doi.org\/10.1353\/hpu.2010.0935","journal-title":"Journal of Health Care for the Poor and Underserved"},{"issue":"1","key":"1460_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12913-019-4469-3","volume":"19","author":"DC O\u2019Brien","year":"2019","unstructured":"O\u2019Brien, D. C., Dabbs, D., Dong, K., Veugelers, P. J., & Hyshka, E. (2019). Patient characteristics associated with being offered take home Naloxone in A busy, urban emergency department: A retrospective chart review. Bmc Health Services Research, 19(1), 632. https:\/\/doi.org\/10.1186\/s12913-019-4469-3","journal-title":"Bmc Health Services Research"},{"key":"1460_CR12","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2934002\/v1","author":"S Nolen","year":"2023","unstructured":"Nolen, S., Trinidad, A. J., Jordan, A. E., Green, T. C., Jalali, A., Murphy, S. M., Zang, X., Marshall, B. D. L., & Schackman, B. R. (2023). Racial\/Ethnic differences in receipt of Naloxone distributed by opioid overdose prevention programs in new York City. Research Square. https:\/\/doi.org\/10.21203\/rs.3.rs-2934002\/v1","journal-title":"Research Square"},{"issue":"1","key":"1460_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12954-022-00700-x","volume":"19","author":"HS Sajwani","year":"2022","unstructured":"Sajwani, H. S., & Williams, A. V. (2022). A systematic review of the distribution of take-home Naloxone in low- and middle-income countries and barriers to the implementation of take-home Naloxone programs. Harm Reduction Journal,19(1), 117. https:\/\/doi.org\/10.1186\/s12954-022-00700-x","journal-title":"Harm Reduction Journal"},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"107589","DOI":"10.1016\/j.drugalcdep.2019.107589","volume":"205","author":"K McCrae","year":"2019","unstructured":"McCrae, K., Tobias, S., Tupper, K., Arredondo, J., Henry, B., Mema, S., Wood, E., & Ti, L. (2019). Drug checking services at music festivals and events in a Canadian setting. Drug and Alcohol Dependence, 205, 107589. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107589","journal-title":"Drug and Alcohol Dependence"},{"key":"1460_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","volume":"190","author":"KW Tupper","year":"2018","unstructured":"Tupper, K. W., McCrae, K., Garber, I., Lysyshyn, M., & Wood, E. (2018). Initial results of a drug checking pilot program to detect Fentanyl adulteration in a Canadian setting. Drug and Alcohol Dependence, 190, 242\u2013245. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.06.020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"1460_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/00952990.2018.1550652","volume":"45","author":"JJ Palamar","year":"2019","unstructured":"Palamar, J. J., Salomone, A., Bigiarini, R., Vincenti, M., Acosta, P., & Tofighi, B. (2019). Testing hair for Fentanyl exposure: A method to inform harm reduction behavior among individuals who use heroin. American Journal of Drug and Alcohol Abuse, 45(1), 90\u201396. https:\/\/doi.org\/10.1080\/00952990.2018.1550652","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"1460_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jsat.2018.01.005","volume":"86","author":"SR Kenney","year":"2018","unstructured":"Kenney, S. R., Anderson, B. J., Conti, M. T., Bailey, G. L., & Stein, M. D. (2018). Expected and actual Fentanyl exposure among persons seeking opioid withdrawal management. Journal of Substance Abuse Treatment, 86, 65\u201369. https:\/\/doi.org\/10.1016\/j.jsat.2018.01.005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"1460_CR18","doi-asserted-by":"publisher","first-page":"109398","DOI":"10.1016\/j.drugalcdep.2022.109398","volume":"234","author":"JJ Palamar","year":"2022","unstructured":"Palamar, J. J., Ciccarone, D., Rutherford, C., Keyes, K. M., Carr, T. H., & Cottler, L. B. (2022). Trends in seizures of powders and pills containing illicit Fentanyl in the united States, 2018 through 2021. Drug and Alcohol Dependence, 234, 109398. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109398","journal-title":"Drug and Alcohol Dependence"},{"key":"1460_CR19","doi-asserted-by":"publisher","first-page":"110819","DOI":"10.1016\/j.drugalcdep.2023.110819","volume":"249","author":"J Friedman","year":"2023","unstructured":"Friedman, J., Godvin, M., Molina, C., Romero, R., Borquez, A., Avra, T., Goodman-Meza, D., Strathdee, S., Bourgois, P., & Shover, C. L. (2023). Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study. Drug and Alcohol Dependence, 249, 110819. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.110819","journal-title":"Drug and Alcohol Dependence"},{"key":"1460_CR20","doi-asserted-by":"publisher","first-page":"108416","DOI":"10.1016\/j.drugalcdep.2020.108416","volume":"218","author":"JN Park","year":"2021","unstructured":"Park, J. N., Rashidi, E., Foti, K., Zoorob, M., Sherman, S., & Alexander, G. C. (2021). Fentanyl and Fentanyl analogs in the illicit stimulant supply: Results from U.S. Drug seizure data, 2011\u20132016. Drug and Alcohol Dependence, 218, 108416. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108416","journal-title":"Drug and Alcohol Dependence"},{"key":"1460_CR21","doi-asserted-by":"publisher","first-page":"104001","DOI":"10.1016\/j.drugpo.2023.104001","volume":"115","author":"JJ Palamar","year":"2023","unstructured":"Palamar, J. J., Le, A., Cleland, C. M., & Keyes, K. M. (2023). Trends in drug use among nightclub and festival attendees in new York City, 2017\u20132022. International Journal of Drug Policy, 115, 104001. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104001","journal-title":"International Journal of Drug Policy"},{"key":"1460_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajem.2020.12.002","volume":"40","author":"P DiSalvo","year":"2021","unstructured":"DiSalvo, P., Cooper, G., Tsao, J., Romeo, M., Laskowski, L. K., Chesney, G., & Su, M. K. (2021). Fentanyl-contaminated cocaine outbreak with laboratory confirmation in new York City in 2019. American Journal of Emergency Medicine, 40, 103\u2013105. https:\/\/doi.org\/10.1016\/j.ajem.2020.12.002","journal-title":"American Journal of Emergency Medicine"},{"issue":"4","key":"1460_CR23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/phn.13193","volume":"40","author":"JJ Palamar","year":"2023","unstructured":"Palamar, J. J. (2023). Awareness that cocaine can contain Fentanyl among nightclub and festival attendees in new York City, 2018\u20132022. Public Health Nursing, 40(4), 566\u2013571. https:\/\/doi.org\/10.1111\/phn.13193","journal-title":"Public Health Nursing"},{"issue":"3","key":"1460_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/phh.0000000000001014","volume":"26","author":"B Allen","year":"2020","unstructured":"Allen, B., Sisson, L., Dolatshahi, J., Blachman-Forshay, J., Hurley, A., & Paone, D. (2020). Delivering opioid overdose prevention in bars and nightclubs: A public awareness pilot in new York City. Journal of Public Health Management and Practice,26(3), 232\u2013235. https:\/\/doi.org\/10.1097\/phh.0000000000001014","journal-title":"Journal of Public Health Management and Practice"},{"key":"1460_CR25","unstructured":"New York City Mayor\u2019s Office of Media and Entertainment, & O. o. N. (2023). NYC Office of Nightlife report 2023\u20132024. New York City Department of Small Business Services. https:\/\/www.nyc.gov\/assets\/sbs\/downloads\/pdf\/about\/reports\/nightlife-report-2023-24.pdf"},{"key":"1460_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.01.013","author":"TC Green","year":"2017","unstructured":"Green, T. C., Case, P., Fiske, H., Baird, J., Cabral, S., Burstein, D., Schwartz, V., Potter, N., Walley, A. Y., & Bratberg, J. (2017). Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. Journal of the American Pharmacists Association. https:\/\/doi.org\/10.1016\/j.japh.2017.01.013","journal-title":"Journal of the American Pharmacists Association"},{"issue":"3","key":"1460_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11524-019-00349-1","volume":"96","author":"E Donovan","year":"2019","unstructured":"Donovan, E., Case, P., Bratberg, J. P., Baird, J., Burstein, D., Walley, A. Y., & Green, T. C. (2019). Beliefs associated with Pharmacy-Based Naloxone: A qualitative study of Pharmacy-Based Naloxone purchasers and people at risk for opioid overdose. Journal of Urban Health,96(3), 367\u2013378. https:\/\/doi.org\/10.1007\/s11524-019-00349-1","journal-title":"Journal of Urban Health"},{"key":"1460_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drugalcdep.2015.05.002","volume":"152","author":"JJ Palamar","year":"2015","unstructured":"Palamar, J. J., Griffin-Tomas, M., & Ompad, D. C. (2015). Illicit drug use among rave attendees in a nationally representative sample of US high school seniors. Drug and Alcohol Dependence, 152, 24\u201331. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.05.002","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"1460_CR29","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/dar.12982","volume":"38","author":"JJ Palamar","year":"2019","unstructured":"Palamar, J. J., Le, A., Acosta, P., & Cleland, C. M. (2019). Consistency of Self-Reported drug use among electronic dance music party attendees. Drug and Alcohol Review, 38(7), 798\u2013806.","journal-title":"Drug and Alcohol Review"},{"issue":"1\u20132","key":"1460_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.drugalcdep.2013.02.007","volume":"132","author":"AV Williams","year":"2013","unstructured":"Williams, A. V., Strang, J., & Marsden, J. (2013). Development of opioid overdose knowledge (OOKS) and attitudes (OOAS) scales for take-home Naloxone training evaluation. Drug and Alcohol Dependence, 132(1\u20132), 383\u2013386. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.02.007","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"1460_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1017\/cem.2018.368","volume":"21","author":"A Kestler","year":"2019","unstructured":"Kestler, A., Giesler, A., Buxton, J., Meckling, G., Lee, M., Hunte, G., Wilkins, J., Marks, D., & Scheuermeyer, F. (2019). Yes, not now, or never: An Analysis of reasons for refusing or accepting emergency department-based take-home Naloxone. Canadian Journal of Emergency Medicine,21(2), 226\u2013234. https:\/\/doi.org\/10.1017\/cem.2018.368","journal-title":"Canadian Journal of Emergency Medicine"},{"issue":"4","key":"1460_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/08897077.2020.1827126","volume":"42","author":"E Skoy","year":"2021","unstructured":"Skoy, E., Werremeyer, A., Steig, J., Eukel, H., Frenzel, O., & Strand, M. (2021). Patient acceptance of Naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose. Substance Abuse & Addiction Journal,42(4), 672\u2013677. https:\/\/doi.org\/10.1080\/08897077.2020.1827126","journal-title":"Substance Abuse & Addiction Journal"},{"issue":"2","key":"1460_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/15360288.2024.2317149","volume":"38","author":"M Hetrick","year":"2024","unstructured":"Hetrick, M. (2024). Yay, or Nay? Over-the-Counter Naloxone nasal spray. Journal of Pain & Palliative Care Pharmacotherapy, 38(2), 185\u2013186. https:\/\/doi.org\/10.1080\/15360288.2024.2317149","journal-title":"Journal of Pain & Palliative Care Pharmacotherapy"},{"issue":"12","key":"1460_CR34","doi-asserted-by":"publisher","first-page":"e22411","DOI":"10.2196\/22411","volume":"4","author":"AS Bennett","year":"2020","unstructured":"Bennett, A. S., Freeman, R., Des Jarlais, D. C., & Aronson, I. D. (2020). Reasons people who use opioids do not accept or carry No-Cost Naloxone: Qualitative interview study. JMIR Formative Research,4(12), e22411. https:\/\/doi.org\/10.2196\/22411","journal-title":"JMIR Formative Research"},{"issue":"1","key":"1460_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/hsc.13409","volume":"30","author":"LA Jackson","year":"2022","unstructured":"Jackson, L. A., Dechman, M., Mathias, H., Gahagan, J., & Morrison, K. (2022). Safety and danger: Perceptions of the implementation of harm reduction programs in two communities in Nova Scotia, Canada. Health and Social Care in the Community, 30(1), 360\u2013371. https:\/\/doi.org\/10.1111\/hsc.13409","journal-title":"Health and Social Care in the Community"},{"issue":"10","key":"1460_CR36","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1176\/appi.ps.201400140","volume":"65","author":"CL Barry","year":"2014","unstructured":"Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014). Stigma, discrimination, treatment effectiveness, and policy: Public views about drug addiction and mental illness. Psychiatric Services, 65(10), 1269\u20131272. https:\/\/doi.org\/10.1176\/appi.ps.201400140","journal-title":"Psychiatric Services"}],"container-title":["Journal of Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-025-01460-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10900-025-01460-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-025-01460-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:45:24Z","timestamp":1757144724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10900-025-01460-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s10900-025-01460-y","relation":{},"ISSN":["0094-5145","1573-3610"],"issn-type":[{"type":"print","value":"0094-5145"},{"type":"electronic","value":"1573-3610"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"27 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Palamar has consulted for the Washington-Baltimore High Intensity Drug Trafficking Areas program. The other authors have no potential conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}